Loading provider…
Loading provider…
Neurology Physician in Los Angeles, CA
NPI: 1073908414Primary Employer
Southern California Permanente Medical Group
healthy.kaiserpermanente.org
HQ Phone
Get MD Elaine's Phone Numberphone_androidMobile
Get MD Elaine's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2017 - 2027
CA State Medical License

American Board of Psychiatry and Neurology
Neurology
Stanford Health Care-Sponsored Stanford University
Fellowship • Neuroimmunology & Multiple Sclerosis
2019 - 2021
Residency • Neurology
2016 - 2019
Alameda Health System-Highland Hospital
Internship • Transitional Year
2015 - 2016
Stanford University School Of Medicine
med.stanford.edu
BA • English Literature
2006 - 2010
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
2011 - 2015
2011 - 2015
Medical School
Until 2015
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 57 | 86 |
| 2 | G2212Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 22 | 31 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 14 | 16 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 14 | 14 |
| 5 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 11 | 11 |
In-depth B cell immunophenotyping to monitor response to anti-CD20 therapy in CNS autoimmunity.
Case Series: Atypical Optic Neuritis After COVID-19 Vaccination.
Authors: Madina Tugizova, Shannon Beres, Prem Subramanian
Journal: J Neuroophthalmol
Publication Date: 2022-01-10
Emergence of rheumatoid arthritis following exposure to natalizumab